SPORANOX Side Effects

6518863-2 |
on Dec 23, 2009 Female patient from CHINA , 41 years of age, weighting 112.4 lb, was diagnosed with pancreatitis and was treated with Sporanox (View Usage). . Sporanox dosage: . During the same period patient was treated with TIENAM (View Tienam Review and Tienam Label ).

6518862-0 |
Patient was taking Sporanox (View Usage). on Dec 23, 2009 from CHINA Additional patient health information: Male patient , 87 years of age, weighting 105.8 lb, was diagnosed with lung infection and. Sporanox dosage: . During the same period patient was treated with MEROPENEM (View Meropenem Review and Meropenem Label ).

6518860-7 |
Adverse event was reported on Dec 23, 2009 by a Female patient taking Sporanox (View Usage) (Dosage: ) was diagnosed with lung infection and. Location: CHINA , 70 years of age, weighting 151.0 lb, . During the same period patient was treated with TEICOPLANIN (View Teicoplanin Review and Teicoplanin Label ).

6518859-0 | Graft Dysfunction, Renal Failure
on Dec 23, 2009 Female patient from CHINA , 18 years of age, weighting 99.21 lb, was diagnosed with escherichia infection, staphylococcal infection (What is staphylococcal infection?) and was treated with Sporanox (View Usage). Patient experienced the following unwanted or unexpected effects: graft dysfunction, renal failure. Sporanox dosage: . During the same period patient was treated with MEROPENEM (View Meropenem Review and Meropenem Label ), LINEZOLID (0.6 Q 12 Hour) (View Linezolid Review and Linezolid Label ).


6518840-1 |
on Dec 23, 2009 Male patient from CHINA , 59 years of age, weighting 121.3 lb, was diagnosed with pharyngitis and was treated with Sporanox (View Usage). . Sporanox dosage: . During the same period patient was treated with AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ).

6518836-X |
Patient was taking Sporanox (View Usage). on Dec 23, 2009 from CHINA Additional patient health information: Male patient , 67 years of age, weighting 158.7 lb, . Sporanox dosage: . During the same period patient was treated with MEROPENEM (View Meropenem Review and Meropenem Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ).

6516108-0 | Abortion Spontaneous
Adverse event was reported on Dec 17, 2009 by a Female patient taking Sporanox (View Usage) (Dosage: ) was diagnosed with vulvovaginal candidiasis and. Location: UNITED KINGDOM , weighting 163.1 lb, Patient experienced the following unwanted or unexpected effects: abortion spontaneous.

6500034-7 | Abdominal Pain, Asthenia, Decreased Appetite, Jaundice, Vomiting
on Dec 10, 2009 Male patient from PERU , 14 years of age, was diagnosed with onychomycosis and was treated with Sporanox (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), asthenia, decreased appetite, jaundice (What is jaundice?), vomiting. Sporanox dosage: . During the same period patient was treated with ADAPALENE (View Adapalene Review and Adapalene Label ).

6482815-1 | Abdominal Pain, Decreased Appetite, Jaundice, Vomiting
on Dec 01, 2009 Male patient from PERU , 14 years of age, was diagnosed with onychomycosis and was treated with Sporanox (View Usage). After Sporanox was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), decreased appetite, jaundice (What is jaundice?), vomiting. Sporanox dosage: . During the same period patient was treated with ADAPALENE (View Adapalene Review and Adapalene Label ).

6456023-4 | Aspergillosis, Histoplasmosis, Lung Disorder
Patient was taking Sporanox (View Usage). Patient experienced the following unwanted or unexpected effects: aspergillosis, histoplasmosis, lung disorder on Nov 16, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 127.0 lb, was diagnosed with histoplasmosis, chronic obstructive pulmonary disease, thrombosis and. Sporanox dosage: . During the same period patient was treated with SPIRIVA (View Spiriva Review and Spiriva Label ), PLAVIX (View Plavix Review and Plavix Label ).

6409787-X | Acute Psychosis, Malaise
Adverse event was reported on Oct 16, 2009 by a Male patient taking Sporanox (View Usage) (Dosage: ) was diagnosed with onychomycosis and. Location: UNITED KINGDOM , 36 years of age, Patient had the following side effects: acute psychosis, malaise.

6400462-4 | Hepatic Fibrosis, Hepatitis Cholestatic
on Oct 07, 2009 Male patient from UNITED STATES , 73 years of age, weighting 162.0 lb, was diagnosed with tinea pedis and was treated with Sporanox (View Usage). After Sporanox was administered, patient had the following side effects: hepatic fibrosis, hepatitis cholestatic. Sporanox dosage: .

6373265-7 | Decreased Immune Responsiveness, Dizziness, Nausea, Pneumonia, Treatment Noncompliance
on Sep 18, 2009 Female patient from BRAZIL , 42 years of age, weighting 101.4 lb, was diagnosed with candidiasis, anxiety (What is anxiety?) and was treated with Sporanox (View Usage). Patient experienced the following unwanted or unexpected effects: decreased immune responsiveness, dizziness (What is dizziness?), nausea (What is nausea?), pneumonia (What is pneumonia?), treatment noncompliance. Sporanox dosage: . During the same period patient was treated with PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ).

6369566-9 | Delusion, Malaise
Patient was taking Sporanox (View Usage). Patient had the following side effects: delusion, malaise on Sep 17, 2009 from UNITED KINGDOM Additional patient health information: Male patient , 36 years of age, was diagnosed with onychomycosis and. Sporanox dosage: .

6358132-7 | Adrenal Disorder, Blood Cholesterol Increased, Body Height Decreased, Colon Cancer, Hypertension, Osteopenia, Pancreatitis, Rectal Haemorrhage, Thyroid Disorder
Adverse event was reported on Sep 15, 2009 by a Female patient taking Sporanox (View Usage) (Dosage: ) was diagnosed with lung infection, aspergillosis and. Location: UNITED STATES , weighting 140.0 lb, After Sporanox was administered, patient had the following side effects: adrenal disorder, blood cholesterol increased, body height decreased, colon cancer, hypertension, osteopenia, pancreatitis, rectal haemorrhage, thyroid disorder. During the same period patient was treated with ITRACONAZOLE (View Itraconazole Review and Itraconazole Label ), ADVAIR HFA (View Advair Hfa Review and Advair Hfa Label ), COMBIVENT (3puffs) (View Combivent Review and Combivent Label ), MINERAL TAB (View Mineral Tab Review and Mineral Tab Label ), VITAMIN (View Vitamin Review and Vitamin Label ).

6317919-7 | Blood Bilirubin Increased
on Aug 19, 2009 Male patient from CHINA , 72 years of age, was diagnosed with antifungal prophylaxis, aplastic anaemia and was treated with Sporanox (View Usage). Patient experienced the following unwanted or unexpected effects: blood bilirubin increased. Sporanox dosage: . During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ).

6297365-5 | Abdominal Pain, Blood Amylase Increased
on Jul 29, 2009 Female patient from UNITED KINGDOM , 43 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with Sporanox (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), blood amylase increased. Sporanox dosage: . During the same period patient was treated with ALENDRONIC ACID (View Alendronic Acid Review and Alendronic Acid Label ), BUDESONIDE (View Budesonide Review and Budesonide Label ), CALCIUM/COLECALCIFEROL (View Calcium/colecalciferol Review and Calcium/colecalciferol Label ), CETIRIZINE (View Cetirizine Review and Cetirizine Label ), FORMOTEROL FUMARATE (View Formoterol Fumarate Review and Formoterol Fumarate Label ), SALBUTAMOL (View Salbutamol Review and Salbutamol Label ).

6292958-3 | Adrenal Disorder, Blood Cholesterol Increased, Body Height Decreased, Colon Cancer, Hypertension, Osteopenia, Pancreatitis, Rectal Haemorrhage, Thyroid Disorder
Patient was taking Sporanox (View Usage). After Sporanox was administered, patient had the following side effects: adrenal disorder, blood cholesterol increased, body height decreased, colon cancer, hypertension, osteopenia, pancreatitis, rectal haemorrhage, thyroid disorder on Jul 23, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 140.0 lb, was diagnosed with lung infection, aspergillosis and. Sporanox dosage: . During the same period patient was treated with ITRACONAZOLE (View Itraconazole Review and Itraconazole Label ), ADVAIR HFA (View Advair Hfa Review and Advair Hfa Label ), COMBIVENT (3puffs) (View Combivent Review and Combivent Label ), MINERAL TAB (View Mineral Tab Review and Mineral Tab Label ), VITAMIN (View Vitamin Review and Vitamin Label ).

6292160-5 | Dysarthria, Eyelid Oedema, Gait Disturbance, Tongue Oedema
Adverse event was reported on Jul 23, 2009 by a Female patient taking Sporanox (View Usage) (Dosage: ) was diagnosed with fungal infection (What is fungal infection?) and. Location: SPAIN , 80 years of age, Patient experienced the following unwanted or unexpected effects: dysarthria, eyelid oedema, gait disturbance, tongue oedema. Patient was hospitalized.

6271226-X | Acute Leukaemia, Chest Pain, Nasopharyngitis, Thrombocytosis
on Jul 10, 2009 Male patient from CHINA , 31 years of age, was diagnosed with onychomycosis and was treated with Sporanox (View Usage). Patient had the following side effects: acute leukaemia, chest pain (What is chest pain?), nasopharyngitis, thrombocytosis. Sporanox dosage: . Patient was hospitalized.

6264520-X | Phlebitis
on Jul 02, 2009 Female patient from CHINA , 90 years of age, was diagnosed with fungal infection (What is fungal infection?) and was treated with Sporanox (View Usage). After Sporanox was administered, patient had the following side effects: phlebitis. Sporanox dosage: . During the same period patient was treated with ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ), APOPHLEGMATISANT (View Apophlegmatisant Review and Apophlegmatisant Label ).

6208608-8 | Acute Leukaemia, Chest Pain, Nasopharyngitis, Thrombocythaemia
Patient was taking Sporanox (View Usage). Patient experienced the following unwanted or unexpected effects: acute leukaemia, chest pain (What is chest pain?), nasopharyngitis, thrombocythaemia on May 21, 2009 from CHINA Additional patient health information: Male patient , 31 years of age, was diagnosed with onychomycosis and. Sporanox dosage: . Patient was hospitalized.

6204059-0 | Retinal Haemorrhage, Visual Impairment
Adverse event was reported on May 22, 2009 by a Male patient taking Sporanox (View Usage) (Dosage: ) was diagnosed with onychomycosis, dyspepsia and. Location: KOREA, REPUBLIC OF , 78 years of age, Patient had the following side effects: retinal haemorrhage, visual impairment. During the same period patient was treated with ALIBENDOL (View Alibendol Review and Alibendol Label ), PIPRINHYDRINATE (View Piprinhydrinate Review and Piprinhydrinate Label ), CLOTRIMAZOLE (View Clotrimazole Review and Clotrimazole Label ).

6178963-6 | Haemorrhage, Surgery
on Apr 29, 2009 Female patient from BRAZIL , 46 years of age, was diagnosed with onychomycosis and was treated with Sporanox (View Usage). After Sporanox was administered, patient had the following side effects: haemorrhage, surgery (What is surgery?). Sporanox dosage: . Patient was hospitalized.

6175765-1 | Phlebitis
on Apr 28, 2009 Female patient from CHINA , 90 years of age, was diagnosed with fungal infection (What is fungal infection?) and was treated with Sporanox (View Usage). Patient experienced the following unwanted or unexpected effects: phlebitis. Sporanox dosage: . During the same period patient was treated with ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ), APOPHLEGMATISANT (View Apophlegmatisant Review and Apophlegmatisant Label ).

6154318-5 | Adrenal Insufficiency, Ascites, Cholestasis, Dyspnoea, Endocrine Neoplasm Malignant, Liver Injury, Muscular Weakness, Oedema Peripheral, Renal Failure
Patient was taking Sporanox (View Usage). Patient had the following side effects: adrenal insufficiency, ascites, cholestasis, dyspnoea, endocrine neoplasm malignant, liver injury, muscular weakness, oedema peripheral, renal failure on Apr 06, 2009 from JAPAN Additional patient health information: Male patient , 65 years of age, was diagnosed with bronchopulmonary aspergillosis, bronchopneumopathy and. Sporanox dosage: 25weeks 6 Days. During the same period patient was treated with ZECLAR (View Zeclar Review and Zeclar Label ), SYMBICORT (View Symbicort Review and Symbicort Label ), SERETIDE (View Seretide Review and Seretide Label ), OFLOXACIN (View Ofloxacin Review and Ofloxacin Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), BRICANYL (View Bricanyl Review and Bricanyl Label ), BRONCHODUAL (View Bronchodual Review and Bronchodual Label ). Patient was hospitalized.

6151075-3 | Adrenal Insufficiency, Ascites, Cholestasis, Dyspnoea, Endocrine Neoplasm Malignant, Liver Injury, Muscular Weakness, Oedema Peripheral, Renal Failure
Adverse event was reported on Mar 23, 2009 by a Male patient taking Sporanox (View Usage) (Dosage: 25weeks 6 Days) was diagnosed with bronchopulmonary aspergillosis, bronchopneumopathy and. Location: JAPAN , 65 years of age, After Sporanox was administered, patient had the following side effects: adrenal insufficiency, ascites, cholestasis, dyspnoea, endocrine neoplasm malignant, liver injury, muscular weakness, oedema peripheral, renal failure. During the same period patient was treated with ZECLAR (View Zeclar Review and Zeclar Label ), SYMBICORT (View Symbicort Review and Symbicort Label ), SERETIDE (View Seretide Review and Seretide Label ), OFLOXACIN (View Ofloxacin Review and Ofloxacin Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), BRICANYL (View Bricanyl Review and Bricanyl Label ), BRONCHODUAL (View Bronchodual Review and Bronchodual Label ). Patient was hospitalized.

6145636-5 | Pancreatitis Acute
on Apr 03, 2009 Female patient from UNITED STATES , 50 years of age, was diagnosed with nail disorder and was treated with Sporanox (View Usage). Patient experienced the following unwanted or unexpected effects: pancreatitis acute. Sporanox dosage: . Patient was hospitalized.

6139213-X | Adrenal Insufficiency, Ascites, Cholestasis, Dyspnoea, Endocrine Neoplasm Malignant, Liver Injury, Muscular Weakness, Oedema Peripheral, Renal Failure
on Mar 23, 2009 Male patient from JAPAN , 65 years of age, was diagnosed with bronchopulmonary aspergillosis, bronchopneumopathy and was treated with Sporanox (View Usage). Patient had the following side effects: adrenal insufficiency, ascites, cholestasis, dyspnoea, endocrine neoplasm malignant, liver injury, muscular weakness, oedema peripheral, renal failure. Sporanox dosage: 25weeks 6 Days. During the same period patient was treated with ZECLAR (View Zeclar Review and Zeclar Label ), SYMBICORT (View Symbicort Review and Symbicort Label ), SERETIDE (View Seretide Review and Seretide Label ), OFLOXACIN (View Ofloxacin Review and Ofloxacin Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), BRICANYL (View Bricanyl Review and Bricanyl Label ), BRONCHODUAL (View Bronchodual Review and Bronchodual Label ). Patient was hospitalized.

6138709-4 | Adrenal Insufficiency, Ascites, Cholestasis, Dyspnoea, Endocrine Neoplasm Malignant, Liver Injury, Muscular Weakness, Oedema Peripheral, Renal Failure
Patient was taking Sporanox (View Usage). After Sporanox was administered, patient had the following side effects: adrenal insufficiency, ascites, cholestasis, dyspnoea, endocrine neoplasm malignant, liver injury, muscular weakness, oedema peripheral, renal failure on Mar 23, 2009 from JAPAN Additional patient health information: Male patient , 65 years of age, was diagnosed with bronchopulmonary aspergillosis, bronchopneumopathy and. Sporanox dosage: 25weeks 6 Days. During the same period patient was treated with ZECLAR (View Zeclar Review and Zeclar Label ), SYMBICORT (View Symbicort Review and Symbicort Label ), SERETIDE (View Seretide Review and Seretide Label ), OFLOXACIN (View Ofloxacin Review and Ofloxacin Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), BRICANYL (View Bricanyl Review and Bricanyl Label ), BRONCHODUAL (View Bronchodual Review and Bronchodual Label ). Patient was hospitalized.

6137609-3 | Dysphagia, Lethargy, Pseudobulbar Palsy, Somnolence
Adverse event was reported on Mar 19, 2009 by a Female patient taking Sporanox (View Usage) (Dosage: ) was diagnosed with fungal skin infection, venous insufficiency, cardiac failure congestive and. Location: COSTA RICA , 85 years of age, Patient experienced the following unwanted or unexpected effects: dysphagia, lethargy, pseudobulbar palsy, somnolence. During the same period patient was treated with CILOSTAZOL (View Cilostazol Review and Cilostazol Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), LASIX (View Lasix Review and Lasix Label ), COREG (Half Tablet Twice A Day) (View Coreg Review and Coreg Label ), LUVOX (View Luvox Review and Luvox Label ), HALCION (View Halcion Review and Halcion Label ), ARICEPT (View Aricept Review and Aricept Label ).

6130691-9 | Dysphagia, Lethargy, Pseudobulbar Palsy, Somnolence
on Mar 19, 2009 Female patient from COSTA RICA , 85 years of age, was diagnosed with fungal skin infection, venous insufficiency, cardiac failure congestive and was treated with Sporanox (View Usage). Patient had the following side effects: dysphagia, lethargy, pseudobulbar palsy, somnolence. Sporanox dosage: . During the same period patient was treated with CILOSTAZOL (View Cilostazol Review and Cilostazol Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), LASIX (View Lasix Review and Lasix Label ), COREG (Half Tablet Twice A Day) (View Coreg Review and Coreg Label ), LUVOX (View Luvox Review and Luvox Label ), HALCION (View Halcion Review and Halcion Label ), ARICEPT (View Aricept Review and Aricept Label ).

6129046-2 | Extremity Necrosis, Gastrointestinal Necrosis
on Mar 12, 2009 Female patient from COLOMBIA , 26 years of age, was treated with Sporanox (View Usage). After Sporanox was administered, patient had the following side effects: extremity necrosis, gastrointestinal necrosis. Sporanox dosage: . During the same period patient was treated with ERGOTAMINA (View Ergotamina Review and Ergotamina Label ).

6128102-2 | Blood Pressure Fluctuation, Burning Sensation, Chest Pain, Chromaturia, Gastrointestinal Disorder, Heart Rate Decreased, Heart Rate Increased, Joint Swelling
Patient was taking Sporanox (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure fluctuation, burning sensation, chest pain (What is chest pain?), chromaturia, gastrointestinal disorder, heart rate decreased, heart rate increased, joint swelling on Mar 20, 2009 from UNITED STATES Additional patient health information: Female patient , 46 years of age, weighting 145.0 lb, was diagnosed with onychomycosis and. Sporanox dosage: 2 Pills Per Dose 2 X Daily Po.

6125306-X | Pseudobulbar Palsy
Adverse event was reported on Mar 15, 2009 by a Female patient taking Sporanox (View Usage) (Dosage: ) was diagnosed with fungal skin infection and. Location: COSTA RICA , 85 years of age, Patient had the following side effects: pseudobulbar palsy. During the same period patient was treated with CILOSTAZOL (View Cilostazol Review and Cilostazol Label ), NAMENDA (View Namenda Review and Namenda Label ), LASIX (View Lasix Review and Lasix Label ), COREG (Half Tablet Twice A Day) (View Coreg Review and Coreg Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), LUVOX (View Luvox Review and Luvox Label ).

6125305-8 | Electrocardiogram Qt Prolonged, Torsade De Pointes
on Mar 13, 2009 Male patient from SWITZERLAND , 31 years of age, was treated with Sporanox (View Usage). After Sporanox was administered, patient had the following side effects: electrocardiogram qt prolonged, torsade de pointes. Sporanox dosage: . During the same period patient was treated with METHADONE HCL (View Methadone Hcl Review and Methadone Hcl Label ), SERESTA (View Seresta Review and Seresta Label ), DORMICUM (View Dormicum Review and Dormicum Label ), PANTOZOL (View Pantozol Review and Pantozol Label ). Patient was hospitalized.

6111441-9 | Cytolytic Hepatitis, Hospitalisation
on Mar 09, 2009 Male patient from FRANCE , 67 years of age, was treated with Sporanox (View Usage). Patient experienced the following unwanted or unexpected effects: cytolytic hepatitis, hospitalisation. Sporanox dosage: . During the same period patient was treated with CERTICAN (View Certican Review and Certican Label ), ELISOR (View Elisor Review and Elisor Label ), FANSIDAR (View Fansidar Review and Fansidar Label ), LEDERFOLINE (View Lederfoline Review and Lederfoline Label ). Patient was hospitalized.

6106955-1 | Abdominal Pain, Fatigue, Insomnia, Renal Pain, Tachycardia
Patient was taking Sporanox (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), fatigue, insomnia, renal pain, tachycardia on Mar 04, 2009 from BRAZIL Additional patient health information: Female patient , 25 years of age, weighting 67.99 lb, was diagnosed with tinea pedis and. Sporanox dosage: .

6105763-5 | Acute Myeloid Leukaemia, Anaphylactic Shock
Adverse event was reported on Mar 06, 2009 by a Female patient taking Sporanox (View Usage) (Dosage: ) was diagnosed with febrile neutropenia and. Location: KOREA, REPUBLIC OF , 68 years of age, After Sporanox was administered, patient had the following side effects: acute myeloid leukaemia, anaphylactic shock.

6092747-9 | Blood Lactate Dehydrogenase Increased
on Feb 24, 2009 Male patient from UNITED STATES , weighting 360.0 lb, was diagnosed with onychomycosis and was treated with Sporanox (View Usage). Patient experienced the following unwanted or unexpected effects: blood lactate dehydrogenase increased. Sporanox dosage: . During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ).

6086500-X | Disease Progression
on Feb 19, 2009 Female patient from KOREA, REPUBLIC OF , weighting 50.71 lb, was diagnosed with febrile neutropenia, infection (What is infection?) and was treated with Sporanox (View Usage). Patient had the following side effects: disease progression. Sporanox dosage: . During the same period patient was treated with TEICOPLANIN (View Teicoplanin Review and Teicoplanin Label ), MEROPENEM (View Meropenem Review and Meropenem Label ).

6076454-4 | Hyperbilirubinaemia
Patient was taking Sporanox (View Usage). After Sporanox was administered, patient had the following side effects: hyperbilirubinaemia on Feb 12, 2009 from KOREA, REPUBLIC OF Additional patient health information: Male patient , weighting 166.4 lb, was diagnosed with febrile neutropenia and. Sporanox dosage: . During the same period patient was treated with AMIKACIN (View Amikacin Review and Amikacin Label ), FLUNAZOLE (View Flunazole Review and Flunazole Label ), PREPENEM (View Prepenem Review and Prepenem Label ). Patient was hospitalized.

6075764-4 | Blood Creatine Phosphokinase Increased, Epigastric Discomfort, Myalgia, Oedema, Transaminases Increased
Adverse event was reported on Feb 05, 2009 by a Male patient taking Sporanox (View Usage) (Dosage: ) was diagnosed with onychomycosis and. Location: SWITZERLAND , weighting 177.5 lb, Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased, epigastric discomfort, myalgia, oedema, transaminases increased.

6074725-9 | Chest Discomfort, Supraventricular Extrasystoles
on Feb 06, 2009 Female patient from CHINA , 60 years of age, was diagnosed with tinea pedis and was treated with Sporanox (View Usage). Patient had the following side effects: chest discomfort, supraventricular extrasystoles. Sporanox dosage: .

6037893-0 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Sepsis
on Jan 12, 2009 Male patient from KOREA, REPUBLIC OF , weighting 132.3 lb, was treated with Sporanox (View Usage). After Sporanox was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, sepsis (What is sepsis?). Sporanox dosage: . Patient was hospitalized.

6033802-9 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Sepsis
Patient was taking Sporanox (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, sepsis (What is sepsis?) on Jan 07, 2009 from KOREA, REPUBLIC OF Additional patient health information: Male patient , 81 years of age, weighting 132.3 lb, . Sporanox dosage: . Patient was hospitalized.

6013178-3 | Anorexia, Dyspepsia, Oedema Peripheral, Skin Disorder
Adverse event was reported on Dec 10, 2008 by a Female patient taking Sporanox (View Usage) (Dosage: ) . Location: FRANCE , 40 years of age, Patient had the following side effects: anorexia, dyspepsia, oedema peripheral, skin disorder. Patient was hospitalized.

6010696-9 | Anorexia, Dyspepsia, Oedema Peripheral, Skin Disorder
on Dec 10, 2008 Female patient from LUXEMBOURG , weighting 154.3 lb, was treated with Sporanox (View Usage). After Sporanox was administered, patient had the following side effects: anorexia, dyspepsia, oedema peripheral, skin disorder. Sporanox dosage: . Patient was hospitalized.

6005435-1 | Laryngeal Cancer, Somnolence
on Dec 15, 2008 Male patient from COLOMBIA , 82 years of age, was diagnosed with onychomycosis and was treated with Sporanox (View Usage). Patient experienced the following unwanted or unexpected effects: laryngeal cancer, somnolence. Sporanox dosage: . During the same period patient was treated with INHALERS (View Inhalers Review and Inhalers Label ), SOMESE (View Somese Review and Somese Label ).

5987180-1 | Headache
Patient was taking Sporanox (View Usage). Patient had the following side effects: headache (What is headache?) on Dec 04, 2008 from FRANCE Additional patient health information: Female patient , 34 years of age, was diagnosed with fungal infection (What is fungal infection?) and. Sporanox dosage: . During the same period patient was treated with KETODERM (View Ketoderm Review and Ketoderm Label ). Patient was hospitalized.